{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:20:38Z","timestamp":1786998038038,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI13\/00456"],"award-info":[{"award-number":["PI13\/00456"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/00829"],"award-info":[{"award-number":["PI15\/00829"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/00337"],"award-info":[{"award-number":["PI16\/00337"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP14\/00121"],"award-info":[{"award-number":["CP14\/00121"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001872","name":"Centro para el Desarrollo Tecnol\u00f3gico Industrial","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001872","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Ministry of Economics and Competitiveness","award":["IDI-20151125"],"award-info":[{"award-number":["IDI-20151125"]}]},{"name":"MINECO","award":["BFU-2011-23604"],"award-info":[{"award-number":["BFU-2011-23604"]}]},{"name":"MINECO","award":["SAF2014-52400-R"],"award-info":[{"award-number":["SAF2014-52400-R"]}]},{"name":"MINECO","award":["SAF2017-87846-R"],"award-info":[{"award-number":["SAF2017-87846-R"]}]},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","award":["S2013\/ABI-2906"],"award-info":[{"award-number":["S2013\/ABI-2906"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n\u00a0Areces","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010784","name":"Banco Santander","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.virol.2018.07.030","type":"journal-article","created":{"date-parts":[[2018,8,11]],"date-time":"2018-08-11T06:10:54Z","timestamp":1533967854000},"page":"100-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Resistance of high fitness hepatitis C virus to lethal mutagenesis"],"prefix":"10.1016","volume":"523","author":[{"given":"Isabel","family":"Gallego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eugenia","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Garc\u00eda-Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Garc\u00eda-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"G\u00f3mez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie","family":"Valiergue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7806-1503","authenticated-orcid":false,"given":"Jordi","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Ignacio","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Quer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celia","family":"Perales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2018.07.030_bib1","unstructured":"AASLD-ISDA, 2018. Hepatitis C virus guidance: recommendations for testing, managing, and treating hepatitis C. \u3008http:\/\/www.hcvguidelines.org\u3009 (Accessed 30 July 2018)."},{"key":"10.1016\/j.virol.2018.07.030_bib2","first-page":"82","article-title":"Emergency services of viral RNAs: repair and remodeling","author":"Agol","year":"2018","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.virol.2018.07.030_bib3","doi-asserted-by":"crossref","first-page":"e1001072","DOI":"10.1371\/journal.ppat.1001072","article-title":"A multi-step process of viral adaptation to a mutagenic nucleoside analogue by modulation of transition types leads to extinction-escape","volume":"6","author":"Agudo","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2018.07.030_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0042-6822(03)00144-2","article-title":"Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis","volume":"311","author":"Airaksinen","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.07.030_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.virol.2015.03.022","article-title":"Viral quasispecies","volume":"479\u2013480","author":"Andino","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.07.030_bib6","doi-asserted-by":"crossref","first-page":"e03679","DOI":"10.7554\/eLife.03679","article-title":"Favipiravir elicits antiviral mutagenesis during virus replication in vivo","volume":"3","author":"Arias","year":"2014","journal-title":"eLife"},{"key":"10.1016\/j.virol.2018.07.030_bib7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jhep.2005.05.032","article-title":"Mutagenic effects of ribavirin and response to interferon\/ribavirin combination therapy in chronic hepatitis C","volume":"43","author":"Asahina","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.virol.2018.07.030_bib8","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.02346-12","article-title":"T-705 (Favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro","volume":"87","author":"Baranovich","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coviro.2014.04.011","article-title":"Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance","volume":"8","author":"Beaucourt","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib10","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","article-title":"Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication","volume":"76","author":"Blight","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib11","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/82191","article-title":"The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen","volume":"6","author":"Crotty","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2018.07.030_bib12","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1128\/JVI.00201-09","article-title":"Effect of ribavirin on the mutation rate and spectrum of hepatitis C virus in vivo","volume":"83","author":"Cuevas","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib13","doi-asserted-by":"crossref","first-page":"e0164691","DOI":"10.1371\/journal.pone.0164691","article-title":"Lethal mutagenesis of hepatitis C virus induced by favipiravir","volume":"11","author":"de Avila","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2018.07.030_bib14","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.virusres.2017.03.014","article-title":"Favipiravir can evoke lethal mutagenesis and extinction of foot-and-mouth disease virus","volume":"233","author":"de Avila","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2018.07.030_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/infdis\/jiy153","article-title":"Extending the antiviral value of favipiravir","volume":"218","author":"de la Torre","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2018.07.030_bib16","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1128\/JVI.02778-12","article-title":"Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patients","volume":"87","author":"Dietz","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.chom.2018.03.012","article-title":"Mapping the evolutionary potential of RNA viruses","volume":"23","author":"Dolan","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virol.2018.07.030_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.micro.51.1.151","article-title":"RNA virus mutations and fitness for survival","volume":"51","author":"Domingo","year":"1997","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.virol.2018.07.030_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1128\/MMBR.05023-11","article-title":"Viral quasispecies evolution","volume":"76","author":"Domingo","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.virol.2018.07.030_bib20","series-title":"The Hypercycle. A Principle of Natural Self-organization","author":"Eigen","year":"1979"},{"key":"10.1016\/j.virol.2018.07.030_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1006\/jmbi.1998.2366","article-title":"Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller's ratchet","volume":"285","author":"Escarm\u00eds","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2018.07.030_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01400-17","article-title":"Extinction of West Nile virus by favipiravir through lethal mutagenesis","volume":"61","author":"Escribano-Romero","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2018.07.030_bib23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-0031-1297925","article-title":"New insights into the HCV quasispecies and compartmentalization","volume":"31","author":"Farci","year":"2011","journal-title":"Sem. Liver Dis."},{"key":"10.1016\/j.virol.2018.07.030_bib24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0076-6879(96)66023-6","article-title":"Progressive alignment of amino acid sequences and construction of phylogenetic trees from them","volume":"266","author":"Feng","year":"1996","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.virol.2018.07.030_bib25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2183\/pjab.93.027","article-title":"Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase","volume":"93","author":"Furuta","year":"2017","journal-title":"Proc. Jpn. Acad. Ser. B Phys. Biol. Sci."},{"key":"10.1016\/j.virol.2018.07.030_bib26","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1128\/AAC.00581-16","article-title":"Barrier-independent, fitness-associated differences in sofosbuvir efficacy against hepatitis C virus","volume":"60","author":"Gallego","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virol.2018.07.030_bib27","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1038\/s41598-018-22620-2","article-title":"Antiviral effect of ribavirin against HCV associated with increased frequency of G-to-A and C-to-U transitions in infectious cell culture model","volume":"8","author":"Galli","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2018.07.030_bib28","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1073\/pnas.0408871102","article-title":"Suppression of viral infectivity through lethal defection","volume":"102","author":"Grande-P\u00e9rez","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2018.07.030_bib29","doi-asserted-by":"crossref","first-page":"12938","DOI":"10.1073\/pnas.182426999","article-title":"Molecular indetermination in the transition to error catastrophe: systematic elimination of lymphocytic choriomeningitis virus through mutagenesis does not correlate linearly with large increases in mutant spectrum complexity","volume":"99","author":"Grande-P\u00e9rez","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2018.07.030_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.virol.2016.03.017","article-title":"Viral quasispecies complexity measures","volume":"493","author":"Gregori","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.07.030_bib31","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/bioinformatics\/btt768","article-title":"Inference with viral quasispecies diversity indices: clonal and NGS approaches","volume":"30","author":"Gregori","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.virol.2018.07.030_bib32","doi-asserted-by":"crossref","first-page":"e1002535","DOI":"10.1371\/journal.pmed.1002535","article-title":"Antiviral efficacy of favipiravir against Ebola virus: a translational study in cynomolgus macaques","volume":"15","author":"Guedj","year":"2018","journal-title":"PLoS Med."},{"key":"10.1016\/j.virol.2018.07.030_bib33","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1128\/jvi.65.6.2960-2967.1991","article-title":"Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses","volume":"65","author":"Holland","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nbt.1604","article-title":"Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system","volume":"28","author":"Jones","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2018.07.030_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/2040206618764483","article-title":"Nucleosides for the treatment of respiratory RNA virus infections","volume":"26","author":"Jordan","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.virol.2018.07.030_bib36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"Lindenbach","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.virol.2018.07.030_bib37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.virusres.2007.12.021","article-title":"HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo","volume":"134","author":"Martinez-Picado","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2018.07.030_bib38","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1128\/jvi.65.7.3954-3957.1991","article-title":"Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies","volume":"65","author":"Mart\u00ednez","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib39","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/hep.22550","article-title":"Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells","volume":"48","author":"Marukian","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.virol.2018.07.030_bib40","doi-asserted-by":"crossref","first-page":"e02505","DOI":"10.1128\/JVI.02505-16","article-title":"Internal disequilibria and phenotypic diversification during replication of hepatitis C virus in a noncoevolving cellular environment","volume":"91","author":"Moreno","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib41","doi-asserted-by":"crossref","first-page":"7246","DOI":"10.1128\/JVI.00614-11","article-title":"Ribavirin can be mutagenic for arenaviruses","volume":"85","author":"Moreno","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib42","doi-asserted-by":"crossref","first-page":"e15135","DOI":"10.1371\/journal.pone.0015135","article-title":"Mutation of HIV-1 genomes in a clinical population treated with the mutagenic nucleoside KP1461","volume":"6","author":"Mullins","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2018.07.030_bib43","doi-asserted-by":"crossref","first-page":"e71039","DOI":"10.1371\/journal.pone.0071039","article-title":"Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis","volume":"8","author":"Ortega-Prieto","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2018.07.030_bib44","doi-asserted-by":"crossref","first-page":"9723","DOI":"10.1128\/JVI.75.20.9723-9730.2001","article-title":"Efficient virus extinction by combinations of a mutagen and antiviral inhibitors","volume":"75","author":"Pariente","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib45","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1128\/JVI.02824-12","article-title":"Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype","volume":"87","author":"Perales","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006421","article-title":"Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis","volume":"12","author":"Qiu","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virol.2018.07.030_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virusres.2016.12.020","article-title":"Deep sequencing in the management of hepatitis virus infections","volume":"239","author":"Quer","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2018.07.030_bib48","first-page":"83","article-title":"Virus fitness: concept, quantification, and application to HIV population dynamics","volume":"299","author":"Quinones-Mateu","year":"2006","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virol.2018.07.030_bib49","first-page":"493","article-title":"A simple method for estimating fifty per cent endpoint","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.virol.2018.07.030_bib50","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1099\/vir.0.80126-0","article-title":"Expansion of host-cell tropism of foot-and-mouth disease virus despite replication in a constant environment","volume":"85","author":"Ruiz-Jarabo","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib51","first-page":"61","article-title":"Quasispecies on fitness landscapes","volume":"392","author":"Schuster","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.virol.2018.07.030_bib52","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0092-8240(88)80059-4","article-title":"Stationary mutant distributions and evolutionary optimization","volume":"50","author":"Schuster","year":"1988","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.virol.2018.07.030_bib53","doi-asserted-by":"crossref","first-page":"12098","DOI":"10.1128\/JVI.01860-14","article-title":"Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus","volume":"88","author":"Sheldon","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib54","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1128\/JVI.01606-06","article-title":"Foot-and-mouth disease virus mutant with decreased sensitivity to ribavirin: implications for error catastrophe","volume":"81","author":"Sierra","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib55","doi-asserted-by":"crossref","first-page":"8316","DOI":"10.1128\/JVI.74.18.8316-8323.2000","article-title":"Response of foot-and-mouth disease virus to increased mutagenesis. Influence of viral load and fitness in loss of infectivity","volume":"74","author":"Sierra","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib56","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1073\/pnas.70.4.1174","article-title":"Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent","volume":"70","author":"Streeter","year":"1973","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2018.07.030_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2005.05.008","article-title":"Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection","volume":"338","author":"Tapia","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.07.030_bib58","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.coviro.2012.07.007","article-title":"Viral fitness: definitions, measurement, and current insights","volume":"2","author":"Wargo","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2018.07.030_bib59","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/35085569","article-title":"Evolution of digital organisms at high mutation rates leads to survival of the flattest","volume":"412","author":"Wilke","year":"2001","journal-title":"Nature"}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218302320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218302320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:47:03Z","timestamp":1758588423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682218302320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":59,"alternative-id":["S0042682218302320"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2018.07.030","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance of high fitness hepatitis C virus to lethal mutagenesis","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2018.07.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}